Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.
Ann Thorac Surg. 2024 Jan;117(1):69-76. doi: 10.1016/j.athoracsur.2023.05.049. Epub 2023 Aug 2.
Both valve-sparing root replacement and composite valve graft (CVG) are acceptable options in aortic root replacement. We compare outcomes of these 2 approaches and durability of the aortic valve.
A consecutive 1635 patients without acute dissection underwent primary aortic root replacement from 1997 to 2022; 473 (29%) underwent valve-sparing root replacement, and 1162 (71%) received CVG. Propensity score matching was used to reduce baseline differences.
The CVG group was older (59 ± 14 years vs 49 ± 14 years; P < .001) with more comorbidities, such as hypertension (88.4% vs 66.4%; P < .001), diabetes (7% vs 1.7%; P < .001), ischemic heart disease (5.1% vs 1.3%; P = .001), pulmonary disease (6.6% vs 1.3%; P < .001), renal impairment (8.6% vs 1.3%; P < .001), class III-IV heart failure (35% vs 9.2%; P < .001), bicuspid aortic valves (44.8% vs 24.1%; P < .001), and severe aortic insufficiency (50.2% vs 13.2%; P < .001). Operative mortality was 0.4% (0% in valve sparing); incidence of major postoperative complications was 2.9% (3.6% vs 1.1%; P = .009). Ten-year survival was 93.1% (91.2% vs 97.7%; hazard ratio [HR], 1.7; 95% CI, 0.9-3.3; P = .120). Mean follow-up was 65 ± 60 months; aortic valve reoperations were similar (5.8% vs 5.7%; HR, 0.8; 95% CI, 0.4-1.4; P = .401). Recurrent moderate-severe aortic insufficiency was less prevalent in CVG (6.1% vs 11.1%; HR, 0.14; 95% CI, 0.07-0.27; P < .001). Propensity score matching identified 225 pairs. There was no difference in 10-year survival or reoperations. Recurrent moderate-severe aortic insufficiency was higher with valve sparing.
Both valve-sparing operations and CVG provide excellent early and late outcomes out to 10 years. Valve sparing is associated with a higher risk for development of aortic insufficiency but no difference in reoperations.
在主动脉根部置换中,保留瓣膜的根部替换和复合瓣膜移植物(CVG)都是可接受的选择。我们比较了这两种方法的结果和主动脉瓣的耐久性。
1997 年至 2022 年,连续 1635 例无急性夹层的患者接受了主动脉根部的初次置换;473 例(29%)接受了保留瓣膜的根部替换,1162 例(71%)接受了 CVG。采用倾向评分匹配来减少基线差异。
CVG 组年龄较大(59 ± 14 岁 vs 49 ± 14 岁;P <.001),合并症更多,如高血压(88.4% vs 66.4%;P <.001)、糖尿病(7% vs 1.7%;P <.001)、缺血性心脏病(5.1% vs 1.3%;P =.001)、肺部疾病(6.6% vs 1.3%;P <.001)、肾功能不全(8.6% vs 1.3%;P <.001)、III-IV 级心力衰竭(35% vs 9.2%;P <.001)、二叶式主动脉瓣(44.8% vs 24.1%;P <.001)和严重主动脉关闭不全(50.2% vs 13.2%;P <.001)。手术死亡率为 0.4%(瓣膜保留组为 0%);主要术后并发症的发生率为 2.9%(3.6% vs 1.1%;P =.009)。10 年生存率为 93.1%(91.2% vs 97.7%;风险比[HR],1.7;95%置信区间,0.9-3.3;P =.120)。平均随访时间为 65 ± 60 个月;主动脉瓣再次手术相似(5.8% vs 5.7%;HR,0.8;95%置信区间,0.4-1.4;P =.401)。CVG 组复发性中重度主动脉关闭不全的发生率较低(6.1% vs 11.1%;HR,0.14;95%置信区间,0.07-0.27;P <.001)。倾向评分匹配确定了 225 对。10 年生存率或再次手术无差异。保留瓣膜与较高的主动脉关闭不全发展风险相关,但再次手术无差异。
保留瓣膜的手术和 CVG 在早期和晚期均可获得极好的结果,最长可达 10 年。保留瓣膜与主动脉关闭不全的发展风险较高相关,但再次手术无差异。